Clinical trial
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 · Sanquin Research & Blood Bank Divisions, Other · Completed
Key facts
| NCT number | NCT00202436 |
|---|---|
| Title | Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy |
| Official title | Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients. |
| Lead sponsor | Sanquin Research & Blood Bank Divisions, Other |
| Collaborators | Maastricht University Medical Center Atrium Medical Center Radboud University Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemochromatosis |
| Intervention type | Procedure |
| Interventions | Phlebotomy, Erythrocytapheresis |
| Enrollment | 40 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 20, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: